CD34 and pterygium: Due to the various postulated etiopathogenesis of pterygium that exists currently, evaluating the effect of intralesional ranibizumab injection on oxidative stress markers in pterygium such as 8-hydroxy-20-deoxyguanosine and on CD34 expression in endothelial cells might be useful.